Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
VKTX
Viking Therapeutics, Inc.
NASDAQ · Pharmaceutical Preparations
Last close
$32.60
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$3.80B
RECENT INSIDER TRADES
2026-08-07
· Kelly-Gemmell Dorothy Elizabeth
(Director)
· OTHER
2026-07-29
· Mancini Marianna
(Chief Operating Officer)
· SELL
2026-07-29
· Lian Brian
(President & CEO)
· SELL
2026-07-29
· ZANTE GREG
(Chief Financial Officer)
· SELL
2026-03-10
· Aubuchon Neil William
(Chief Commercial Officer)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
481
Shares held
95,554,406
Value
$3.75B
Percent of shares outstanding
81.91%
As of quarter end
2026-06-30
RECENT NEWS
Viking Therapeutics initiates oral maintenance dosing study
Viking Therapeutics initiates oral maintenance dosing trial for VK2735 in obesity
Viking Therapeutics raises $550M in offering
Viking Therapeutics closes upsized stock and convertible note offerings
Viking Therapeutics Adds Weight Loss Maintenance As Potential New Growth Driver
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Viking Therapeutics, Inc. (VKTX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit